Oncology Analytics announced the release of Oncology Insights, a next-generation analytics software solution that delivers current, relevant, and structured oncology data, supported by expert...
Liquid biopsy test provider Biocept has announced Target Selector NGS Breast Panel, a multi-gene liquid biopsy panel specifically developed for breast cancer. The Target...
Cancer diagnostics company Genecast has launched of ADPS BRAF, EGFR, JAK2 mutation test kits with the highest detection sensitivity. Currently available for research use...
HDPCR Tick-Borne Pathogen (TBP) Panel is a multiplexPCR test that detects nine of the most common tick-borne pathogens in a single test.
The ZymoPURE™ Plasmid Miniprep Kit yields up to 80 µg of ultra-pure and highly concentrated plasmid DNA.
The kit consists of all the components required to generate small RNA libraries to be used for next-gen sequencing.
ChIP-Seq Spike-in corrects for technical variation that occurs as a result of the multistep ChIP/ChIP-Seq protocols.
Users can sequence up to 48 human genomes, or 384 exomes per run in less than 48 hours.
MDxHealth has launched its AssureMD for Bladder Cancer test in the U.S. as a laboratory developed test (LDT).
The ExoDx™ Lung(ALK), is the first liquid biopsy test designed to isolate and analyze exosomal RNA (exoRNA) from a blood sample.